Essential role of interleukin-6 in post-stroke angiogenesis.

Ambivalent effects of interleukin-6 on the pathogenesis of ischaemic stroke have been reported. However, to date, the long-term actions of interleukin-6 after stroke have not been investigated. Here, we subjected interleukin-6 knockout (IL-6(-/-)) and wild-type control mice to mild brain ischaemia by 30-min filamentous middle cerebral artery occlusion/reperfusion. While ischaemic tissue damage was comparable at early time points, IL-6(-/-) mice showed significantly increased chronic lesion volumes as well as worse long-term functional outcome. In particular, IL-6(-/-) mice displayed an impaired angiogenic response to brain ischaemia with reduced numbers of newly generated endothelial cells and decreased density of perfused microvessels along with lower absolute regional cerebral blood flow and reduced vessel responsivity in ischaemic striatum at 4 weeks. Similarly, the early genomic activation of angiogenesis-related gene networks was strongly reduced and the ischaemia-induced signal transducer and activator of transcription 3 activation observed in wild-type mice was almost absent in IL-6(-/-) mice. In addition, systemic neoangiogenesis was impaired in IL-6(-/-) mice. Transplantation of interleukin-6 competent bone marrow into IL-6(-/-) mice (IL-6(chi)) did not rescue interleukin-6 messenger RNA expression or the early transcriptional activation of angiogenesis after stroke. Accordingly, chronic stroke outcome in IL-6(chi) mice recapitulated the major effects of interleukin-6 deficiency on post-stroke regeneration with significantly enhanced lesion volumes and reduced vessel densities. Additional in vitro experiments yielded complementary evidence, which showed that after stroke resident brain cells serve as the major source of interleukin-6 in a self-amplifying network. Treatment of primary cortical neurons, mixed glial cultures or immortalized brain endothelia with interleukin 6-induced robust interleukin-6 messenger RNA transcription in each case, whereas oxygen-glucose deprivation did not. However, oxygen-glucose deprivation of organotypic brain slices resulted in strong upregulation of interleukin-6 messenger RNA along with increased transcription of key angiogenesis-associated genes. In conclusion, interleukin-6 produced locally by resident brain cells promotes post-stroke angiogenesis and thereby affords long-term histological and functional protection.

[1]  M. Salifu,et al.  Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines , 2011, Journal of Translational Medicine.

[2]  G. Li,et al.  Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway , 2011, Oncogene.

[3]  W. Muller,et al.  Mechanisms of leukocyte transendothelial migration. , 2011, Annual review of pathology.

[4]  Longxuan Li,et al.  Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1 , 2010, Journal of Neuroinflammation.

[5]  M. Endres,et al.  CD93/AA4.1: A Novel Regulator of Inflammation in Murine Focal Cerebral Ischemia , 2010, The Journal of Immunology.

[6]  F. Heppner,et al.  Formation and maintenance of Alzheimer’s disease beta-amyloid plaques in the absence of microglia , 2010 .

[7]  F. Heppner,et al.  Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia , 2009, Nature Neuroscience.

[8]  J. Hengstler,et al.  P2 receptor‐mediated stimulation of the PI3‐K/Akt‐pathway in vivo , 2009, Glia.

[9]  M. Chopp,et al.  eNOS Mediates TO90317 Treatment-Induced Angiogenesis and Functional Outcome After Stroke in Mice , 2009, Stroke.

[10]  G. Norman,et al.  Social isolation alters neuroinflammatory response to stroke , 2009, Proceedings of the National Academy of Sciences.

[11]  M. Endres,et al.  Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome , 2009, Experimental Neurology.

[12]  K. Arai,et al.  Mechanisms and targets for angiogenic therapy after stroke , 2009, Cell adhesion & migration.

[13]  Kortaro Tanaka,et al.  Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic Aspects , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Masahito Watanabe,et al.  IN MICE , 2009 .

[15]  F. Schaper,et al.  Interleukin‐6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration , 2008, Journal of leukocyte biology.

[16]  R. Peixoto,et al.  Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. , 2008, Journal of neuroinflammation.

[17]  S. Akira,et al.  STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury , 2008, The Journal of Neuroscience.

[18]  V. Kaushal,et al.  Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra , 2008, The Journal of Neuroscience.

[19]  Yiqian Zhu,et al.  Interleukin-6 Stimulates Circulating Blood-Derived Endothelial Progenitor Cell Angiogenesis in vitro , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  U. Laufs,et al.  The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients With Coronary Artery Disease and Normal Glucose Tolerance , 2007, Diabetes.

[21]  M. Endres,et al.  Phosphatidylinositol 3-Akt-Kinase-Dependent Phosphorylation of p21Waf1/Cip1 as a Novel Mechanism of Neuroprotection by Glucocorticoids , 2007, The Journal of Neuroscience.

[22]  Á. Chamorro,et al.  Signalling pathways mediating inflammatory responses in brain ischaemia. , 2006, Biochemical Society transactions.

[23]  Ulrich Dirnagl,et al.  Physical Activity Improves Long-Term Stroke Outcome via Endothelial Nitric Oxide Synthase–Dependent Augmentation of Neovascularization and Cerebral Blood Flow , 2006, Circulation research.

[24]  M. Endres,et al.  Abstract 2393: Physical Activity Improves Long-Term Stroke Outcome via eNOS-Dependent Augmentation of Neo-Vascularization and Cerebral Blood Flow , 2006 .

[25]  P. Gass,et al.  IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors , 2006, Neurobiology of Disease.

[26]  B. Rosen,et al.  Role of matrix metalloproteinases in delayed cortical responses after stroke , 2006, Nature Medicine.

[27]  S. Asai,et al.  Screening for control genes in mouse hippocampus after transient forebrain ischemia using high-density oligonucleotide array. , 2006, Journal of pharmacological sciences.

[28]  M. Endres,et al.  Nestin-Expressing Cells Divide and Adopt a Complex Electrophysiologic Phenotype after Transient Brain Ischemia , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  H. Okano,et al.  Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons , 2005, Journal of neurochemistry.

[30]  C. Birchmeier,et al.  A Role for E2F6 in the Restriction of Male-Germ-Cell-Specific Gene Expression , 2005, Current Biology.

[31]  J. Aarseth,et al.  IL‐6: an early marker for outcome in acute ischemic stroke , 2005, Acta neurologica Scandinavica.

[32]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis (vol 11, pg 146, 2005) , 2005 .

[33]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[34]  N. Khaper,et al.  Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.

[35]  Samuel H. Wilson,et al.  Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. , 2004, The Journal of clinical investigation.

[36]  D. Bullard,et al.  Intercellular Adhesion Molecule-1 (ICAM-1) Regulates Endothelial Cell Motility through a Nitric Oxide-dependent Pathway* , 2004, Journal of Biological Chemistry.

[37]  N. Rothwell,et al.  Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome , 2004, BMC neurology.

[38]  M. Endres,et al.  Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. , 2003, Circulation.

[39]  G. Kempermann,et al.  Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli , 2003, The Journal of comparative neurology.

[40]  A. Słowik,et al.  Interleukin-6 and stroke: cerebral ischemia versus nonspecific factors influencing interleukin-6. , 2003, Stroke.

[41]  R. Keep,et al.  The Protective Effects of Preconditioning on Cerebral Endothelial Cells in Vitro , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  M. Endres,et al.  Mechanisms of stroke protection by physical activity , 2003, Annals of neurology.

[43]  K. Sayama,et al.  Nuclear Translocation of Phosphorylated STAT3 Is Essential for Vascular Endothelial Growth Factor-induced Human Dermal Microvascular Endothelial Cell Migration and Tube Formation* , 2003, Journal of Biological Chemistry.

[44]  Ulrich Dirnagl,et al.  Selective Neuronal Vulnerability Following Mild Focal Brain Ischemia in the Mouse , 2003, Brain pathology.

[45]  S. Mousa,et al.  Signaling through JAM-1 and αvβ3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and αvβ3 complex , 2003 .

[46]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[47]  A. Grau,et al.  Multiple Levels of Regulation of the Interleukin-6 System in Stroke , 2003, Stroke.

[48]  N. Mukaida,et al.  Essential involvement of IL‐6 in the skin wound‐healing process as evidenced by delayed wound healing in IL‐6‐deficient mice , 2003, Journal of leukocyte biology.

[49]  H. Monyer,et al.  Regulation of Body Temperature and Neuroprotection by Endogenous Interleukin-6 in Cerebral Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  S. Mousa,et al.  Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. , 2003, Blood.

[51]  Michael Chopp,et al.  A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia , 2002, Journal of Neuroscience Methods.

[52]  M. Schwaninger,et al.  Interleukin-6 (IL-6): A Possible Neuromodulator Induced by Neuronal Activity , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[53]  D. Levy,et al.  What does Stat3 do? , 2002, The Journal of clinical investigation.

[54]  Paul J. McMillan,et al.  Angiogenesis after Stroke is Correlated with Increased Numbers of Macrophages: The Clean-up Hypothesis , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  S. Terakawa,et al.  Tissue-Type Plasminogen Activator is Involved in the Process of Neuronal Death Induced by Oxygen–Glucose Deprivation in Culture , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  M. Luster,et al.  Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  S. Namura,et al.  Serine–Threonine Protein Kinase Akt does Not Mediate Ischemic Tolerance after Global Ischemia in the Gerbil , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  M. Lautenschlager,et al.  Melatonin is protective in necrotic but not in caspasedependent, free radical‐independent apoptotic neuronal cell death in primary neuronal cultures , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  F. Eckenstein,et al.  Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. , 2000, Stroke.

[60]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[61]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[62]  R. Jaenisch,et al.  DNA Methyltransferase Contributes to Delayed Ischemic Brain Injury , 2000, The Journal of Neuroscience.

[63]  U. Dirnagl,et al.  Role of nitric oxide in the ethylcholine aziridinium model of delayed apoptotic neurodegeneration in vivo and in vitro , 2000, Neuroscience.

[64]  R. Jaenisch,et al.  Ischemic Brain Damage in Mice after Selectively Modifying BDNF or NT4 Gene Expression , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[65]  C. Coe,et al.  Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli , 1999, Brain Research.

[66]  P. Carmeliet,et al.  Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.

[67]  Jae-Wook Oh,et al.  Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor , 1999, The Journal of Neuroscience.

[68]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[69]  K. Hossmann,et al.  Differences in the cerebrovascular anatomy of C57Black/6 and SV129 mice , 1998, Neuroreport.

[70]  O. Witte,et al.  Focal ischaemia of the rat brain elicits an unusual inflammatory response: early appearance of CD8+ macrophages/microglia , 1998, The European journal of neuroscience.

[71]  N. Rothwell,et al.  Cerebral Interleukin-6 is Neuroprotective during Permanent Focal Cerebral Ischemia in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[72]  C. Garlanda,et al.  Involvement of endothelial PECAM-1/CD31 in angiogenesis. , 1997, The American journal of pathology.

[73]  G. Neufeld,et al.  Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[74]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[75]  F. Holsboer,et al.  Cellular Localization of Interleukin 6 mRNA and Interleukin 6 Receptor mRNA in Rat Brain , 1993, The European journal of neuroscience.

[76]  M. Wadhwa,et al.  Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production , 1991, Journal of Neuroimmunology.

[77]  W. Kuschinsky,et al.  Congruence of total and perfused capillary network in rat brains. , 1990, Circulation research.